Literature DB >> 11090790

Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation.

R H Mehta1, M A Supiano, H Oral, P M Grossman, J A Petrusha, D G Montgomery, K A Briesmiester, M J Smith, M R Starling.   

Abstract

We have previously demonstrated that the systemic sympathetic nervous system (SNS) is activated in proportion to an increase in cineventriculographic left ventricular (LV) end-systolic volume and decrease in ejection fraction (EF) in patients with chronic mitral regurgitation (MR). However, the relation between noninvasive echocardiographic measures of LV size and performance and systemic SNS activation and their clinical implications in patients with MR is not known. We studied 17 MR patients with echocardiography, arterial norepinephrine (NE) sampling, and [3H]-NE infusions and arterial blood sampling to determine NE kinetic parameters using a 2-compartment analysis, including extravascular NE release rates (NE2, index of SNS activity) and the metabolic clearance rate from the vascular compartment. The arterial NE values correlated with LV end-systolic dimensions (r = 0.50, p = 0.04), but not with LV end-diastolic dimensions, and EF or fractional shortening measures. The NE2 values correlated with LV end-systolic dimensions (r = 0.53, p = 0.03) and inversely with LVEF (r = -0.45, p = 0.07) and fractional shortening (r = 0.43, p = 0.08) measures, but not with LV end-diastolic dimensions. The metabolic clearance rate values showed an inverse correlation with LV end-diastolic (r = -0.52, p = 0.03) and end-systolic (r = -0.49, p = 0.04) dimensions, but not with LV performance measures. The increase in NE2 values was progressive as the LV endsystolic dimensions increased and more marked at LV end-systolic dimensions > or = 40 mm. Thus, activation of the SNS is related to an increase in echocardiographic LV end-systolic dimensions and a decrease in LV performance measures in chronic MR. Medica, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090790     DOI: 10.1016/s0002-9149(00)01201-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Differential Expression of the Angiotensin-(1-12)/Chymase Axis in Human Atrial Tissue.

Authors:  Hao Wang; Jasmina Varagic; Sayaka Nagata; Neal D Kon; Sarfaraz Ahmad; Jessica L VonCannon; Kendra N Wright; Xuming Sun; Dwight Deal; Leanne Groban; Carlos M Ferrario
Journal:  J Surg Res       Date:  2020-04-30       Impact factor: 2.192

Review 2.  The renin-angiotensin system in mitral regurgitation: a typical example of tissue activation.

Authors:  Louis J Dell'Italia
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

3.  Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.

Authors:  Sayaka Nagata; Jasmina Varagic; Neal D Kon; Hao Wang; Leanne Groban; Stephen W Simington; Sarfaraz Ahmad; Louis J Dell'Italia; Jessica L VonCannon; Dwight Deal; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-06-16

4.  Cardiac mechanics are impaired during fatiguing exercise and cold pressor test in healthy older adults.

Authors:  Matthew D Muller; Jessica L Mast; Hardikkumar Patel; Lawrence I Sinoway
Journal:  J Appl Physiol (1985)       Date:  2012-11-15

Review 5.  Exploring the biology of valvular heart disease: Time to move into the twenty-first century.

Authors:  Blase A Carabello
Journal:  Glob Cardiol Sci Pract       Date:  2013-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.